Journal of Geriatric Psychiatry and Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mintzer, J.
Right arrow Articles by Targum, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mintzer, J.
Right arrow Articles by Targum, S. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Geriatric Psychiatry and Neurology, Vol. 16, No. 4, 199-206 (2003)
DOI: 10.1177/0891988703258658
© 2003 SAGE Publications

Psychosis in Elderly Patients: Classification and Pharmacotherapy

Jacobo Mintzer, MD

Medical University of South Carolina, Institute of Psychiatry, Charlestonmintzerj{at}musc.edu

Steven D. Targum, MD

Clinical Studies Ltd

Psychosis in elderly patients is a growing clinical concern because psychotic symptoms most frequently occur as noncognitive manifestations of Alzheimer’s disease, as side effects of drug therapy for Parkinson’s disease, or as the primary abnormalities in schizophrenia, and the clinical characteristics of psychosis are distinct for each. In planning antipsychotic pharmacotherapy for elderly patients, age-related pharmacokinetic changes, polypharmacy for comorbid diseases, and concerns about the underlying conditions responsible for the psychotic symptoms must be considered. Traditional antipsychotic agents bind to dopamine receptors and effectively relieve positive schizophrenic symptoms but frequently cause tardive dyskinesia and other extrapyramidal symptoms, a problem for elderly patients, particularly for those with Parkinson’s disease. Atypical antipsychotics bind to dopamine and serotonin receptors, relieving both positive and negative symptoms, and are less likely to cause extrapyramidal symptoms. The authors review common diagnostics associated with psychosis in the elderly and clinical guidelines to selecting antipsychotic pharmacotherapy.

Key Words: psychosis • elderly • pharmacotherapy • atypical antipsychotics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
S. Karim and E. J. Byrne
Treatment of psychosis in elderly people
Advan. Psychiatr. Treat., July 1, 2005; 11(4): 286 - 296.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
J. A. Cheong
An Evidence-Based Approach to the Management of Agitation in the Geriatric Patient
Focus, April 1, 2004; 2(2): 197 - 205.
[Full Text] [PDF]